21/05/26

De Brauw x hollandbio: Scaling Beyond Series C

Late-stage life sciences and healthcare companies (Series C/D and beyond) face fundamentally different challenges compared to early-stage ventures. Funding rounds become larger and more complex, investors apply stricter requirements, and governance and cross-border considerations carry greater weight.

Access to growth capital is one of the central themes within the Dutch life sciences ecosystem and closely aligns with hollandbio’s advocacy priorities. Strengthening the funding environment for scaling biotech and healthcare companies is essential to maintaining the Netherlands’ international competitive position. This joint event aims to contribute to that goal.

Program

15:30 – Walk in
16:00 – Start program
17:00 – Networking drinks

This event will take place on May 21 at the Amsterdam office of De Brauw Blackstone Westbroek.

A registration link will follow soon.

door Idalia Dlugosz